title: Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells.
abstract: Pulse treatment of U-937 promonocytic cells with cadmium chloride (2 h at 200 microM) provoked apoptosis and induced a rapid phosphorylation of p38 mitogen-activated protein kinase (p38(MAPK)) as well as a late phosphorylation of extracellular signal-regulated protein kinases (ERK1/2). However, although the p38(MAPK)-specific inhibitor SB203580 attenuated apoptosis, the process was not affected by the ERK-specific inhibitor PD98059. The attenuation of the cadmium-provoked apoptosis by SB203580 was a highly specific effect. In fact, the kinase inhibitor did not prevent the generation of apoptosis by heat shock and camptothecin, nor the generation of necrosis by cadmium treatment of glutathione-depleted cells, nor the cadmium-provoked activation of the stress response. The generation of apoptosis was preceded by intracellular H(2)O(2) accumulation and was accompanied by the disruption of mitochondrial transmembrane potential, both of which were inhibited by SB203580. On the other hand, the antioxidant agent butylated hydroxyanisole-inhibited apoptosis but did not prevent p38(MAPK) phosphorylation. In a similar manner, p38(MAPK) phosphorylation was not affected by the caspase inhibitors Z-VAD and DEVD-CHO, which nevertheless prevented apoptosis. These results indicate that p38(MAPK) activation is an early and specific regulatory event for the cadmium-provoked apoptosis in promonocytic cells.
authors.affiliation: Centro de Investigaciones Biológicas, CSIC, 28006 Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Galán
authors.forename: M L
authors.initials: ML
authors.lastname: García-Bermejo
authors.forename: A
authors.initials: A
authors.lastname: Troyano
authors.forename: N E
authors.initials: NE
authors.lastname: Vilaboa
authors.forename: E
authors.initials: E
authors.lastname: de Blas
authors.forename: M G
authors.initials: MG
authors.lastname: Kazanietz
authors.forename: P
authors.initials: P
authors.lastname: Aller
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D002104:Cadmium / Q000633:toxicity*; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000502:physiology*; D020169:Caspases / Q000378:metabolism; D004789:Enzyme Activation; D005419:Flavonoids / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008564:Membrane Potentials; D008928:Mitochondria / Q000502:physiology; D019950:Mitogen-Activated Protein Kinase 1 / Q000502:physiology; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D009336:Necrosis; D018384:Oxidative Stress; D011725:Pyridines / Q000494:pharmacology; D020298:U937 Cells; D048051:p38 Mitogen-Activated Protein Kinases
chemical_list: D005419:Flavonoids; D007093:Imidazoles; D011725:Pyridines; D002104:Cadmium; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D020169:Caspases; C093642:SB 203580; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one